webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-Val-Ala-PAB-OH

  CAS No.: 1394238-91-5   Cat No.: BADC-00942   Purity: >98.0%(HPLC)(N) 4.5  

Fmoc-Val-Ala-PAB-OH is a peptide-based ADC linker intermediate with Fmoc protection, designed for enzyme-sensitive payload release and controlled conjugation in antibody-drug conjugates. Keywords: ADC linker, peptide linker, Fmoc protection, controlled release, payload conjugation.

Fmoc-Val-Ala-PAB-OH

Structure of 1394238-91-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C30H33N3O5
Molecular Weight
515.60
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
500 mg $298 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-Val-Ala-PAB; (9H-Fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate
IUPAC Name
9H-fluoren-9-ylmethyl N-[(2S)-1-[[(2S)-1-[4-(hydroxymethyl)anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
Canonical SMILES
CC(C)C(C(=O)NC(C)C(=O)NC1=CC=C(C=C1)CO)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
InChI
InChI=1S/C30H33N3O5/c1-18(2)27(29(36)31-19(3)28(35)32-21-14-12-20(16-34)13-15-21)33-30(37)38-17-26-24-10-6-4-8-22(24)23-9-5-7-11-25(23)26/h4-15,18-19,26-27,34H,16-17H2,1-3H3,(H,31,36)(H,32,35)(H,33,37)/t19-,27-/m0/s1
InChIKey
PIEQFKSWCKVBTP-PPHZAIPVSA-N
Density
1.3±0.1 g/cm3
Solubility
10 mm in DMSO
Melting Point
218 °C(dec.)
Flash Point
444.4±34.3 °C
Index Of Refraction
1.620
Vapor Pressure
0.0±3.0 mmHg at 25°C
Appearance
White to light yellow powder to crystal
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Boiling Point
811.1±65.0 °C at 760 mmHg
Form
Solid

Fmoc-Val-Ala-PAB-OH, a synthetic peptide prominent in biochemical and pharmaceutical research, finds diverse applications across various fields.

Peptide Synthesis: Acting as a fundamental building block in peptide synthesis, Fmoc-Val-Ala-PAB-OH facilitates the construction of intricate peptide chains through solid-phase techniques. The inclusion of its Fmoc (9-fluorenylmethyloxycarbonyl) group enables sequential peptide assembly, ensuring the production of highly pure peptides essential for a myriad of research and therapeutic endeavors.

Drug Development: In the realm of pharmaceutical innovation, Fmoc-Val-Ala-PAB-OH plays a pivotal role in the design and synthesis of peptide-based drug candidates. These peptides, capable of mimicking natural biological molecules, target specific physiological pathways, with researchers customizing peptide sequences and structures to enhance therapeutic efficacy and safety profiles.

Protease Substrate: Serving as a vital substrate for investigating protease activity, Fmoc-Val-Ala-PAB-OH allows researchers to delve into the specificity and kinetic properties of proteases, pivotal players in a myriad of biological processes. Through such studies, researchers unearth potential protease inhibitors or activators crucial in combatting diseases like cancer and inflammatory disorders, a testament to the peptide’s versatility in biomedical research.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bocaminooxyacetamide-PEG3-alkyne | Boc-Aminooxy-PEG2-bromide | Macropa-NCS | Indole-C2-amide-C2-NH2 | Aminooxy-PEG2-BCN | Aminooxy-PEG4-alcohol | DC-1 | Maytansinoid DM4 | Fmoc-N-amido-PEG2-acetic acid | NHS-PEG4-azide | Fmoc-Val-Ala-PAB-OH
Send Inquiry
Verification code
Inquiry Basket